Treatment of Agitation by drug Aerosol Inhalation

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$196,998.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43MH068926-01A1
Agency Tracking Number:
MH068926
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
ALEXZA MOLECULAR DELIVERY CORPORATION
ALEXZA MOLECULAR DELIVERY CORPORATION, 1001 E MEADOW CIR, PALO ALTO, CA, 94303
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 PATRIK Munzar
 (650) 687-3922
 PMUNZAR@ALEXZA.COM
Business Contact
 JOSHUA RABINOWITZ
Phone: (650) 687-3902
Email: JRABINOWITZ@ALEXZA.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Acute agitation is a serious and common complication of a variety of major psychiatric disorders, including dementia, schizophrenia and mania. In addition, it is one of the most detrimental factors in the continued

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government